IDEXX officer Michael J. Lane proposes $2.74M share sale
The proposed sale consists of shares acquired through employee stock purchases, restricted-stock vesting and stock-option exercises.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Michael J. Lane, an officer of IDEXX Laboratories, Inc., reported a proposed sale of 3,979 shares of common stock, with an aggregate market value of $2,740,107.92 and an approximate sale date of November 4, 2026. The listed shares comprise 243 Employee Stock Purchase Plan shares, 2,059 restricted-stock shares, and 1,677 shares acquired through stock-option exercises.
Key Figures
Key Terms
Rule 144 regulatory
Employee Stock Purchase Plan financial
Restricted Stock financial
Stock Options financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.